IL16 - C-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-IL16 - C-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | IL16 - C-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | goat, horse, human, porcine |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This is a rabbit polyclonal antibody against IL16. It was validated on Western BlotTarget Description: The protein encoded by this gene is a pleiotropic cytokine that functions as a chemoattractant, a modulator of T cell activation, and an inhibitor of HIV replication. The signaling process of this cytokine is mediated by CD4. The product of this gene undergoes proteolytic processing, which is found to yield two functional proteins. The cytokine function is exclusively attributed to the secreted C-terminal peptide, while the N-terminal product may play a role in cell cycle control. Caspase 3 is reported to be involved in the proteolytic processing of this protein. Alternate splicing results in multiple transcript variants. |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the C-terminal region of Human IL16 |
| Other Names | [pro-interleukin-16 isoform 1; Pro-interleukin-16; pro-interleukin-16; interleukin 16; Lymphocyte chemoattractant factor] |
| Gene, Accession # | [IL16], Gene ID: 3603, NCBI: NP_004504, UniProt: Q14005 |
| Catalog # | MBS3215161 |
| Price | $335 |
| Order / More Info | IL16 - C-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies